Loading viewer...
earnings
Format: PDF earnings
Dow reported 2Q 2024 net sales of $10.9B, down 4% year-over-year, while achieving the third consecutive quarter of volume growth. Operating EBITDA reached $1.5B with operating cash flow of $832MM and $691MM returned to shareholders, reflecting maintained operational and financial discipline.
investor_presentation
110 Pages
earnings
28 Pages
Veritiv Corporation
Alembic Pharmaceuticals Q4 FY25 Investor Presentation 2025
earningsearnings
24 Pages
Alembic Pharmaceuticals